✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Hemo Organic Ltd.

HEMORGANIC

Market Cap
₹3 Cr.
P/E
0.00

Hemo Organic Ltd.

  • Hemo Organic
  • Raymed Labs
  • Zyden Gentec
FAQs on Hemo Organic Ltd. Shareprice

Hemo Organic has given lower returns compared to its competitors.
Hemo Organic has grown at ~-43.52% over the last 3yrs while peers have grown at a median rate of 16.48%

Hemo Organic is not expensive.
Latest PE of Hemo Organic is 0.0, while 3 year average PE is 6.9.
Also latest EV/EBITDA of Hemo Organic is 0.0 while 3yr average is 3.16.

View FAQ's On Business
Growth Table
  • Hemo Organic Ltd.
  • Raymed Labs
  • Zyden Gentec
Balance Sheet
  • Hemo Organic Ltd.
  • Raymed Labs
  • Zyden Gentec
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Hemo Organic Ltd.
  • Raymed Labs
  • Zyden Gentec
Cash Flow
  • Hemo Organic Ltd.
  • Raymed Labs
  • Zyden Gentec
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Hemo Organic Ltd.
  • Raymed Labs
  • Zyden Gentec
Quarterly Results
  • Hemo Organic Ltd.
  • Raymed Labs
  • Zyden Gentec
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Hemo Organic Ltd. Financials

Hemo Organic balance sheet is weak and might have solvency issues

Yes, The debt of Hemo Organic is increasing.
Latest debt of Hemo Organic is ₹1.24 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹1 Crs.

The profit is oscillating.
The profit of Hemo Organic is -₹0.26 Crs for Mar 2024, -₹0.05 Crs for Mar 2023 and -₹0.06 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Hemo Organic latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech